Archives
-
HyperFusion high-fidelity DNA polymerase in C. elegans
2026-09-09
Use HyperFusion™ high-fidelity DNA polymerase to generate accurate, blunt-ended amplicons for C. elegans genotyping, pathway validation, cloning, and sequencing. Its proofreading activity and tolerance of difficult templates make it especially useful when GC-rich loci, long amplicons, or inhibitor-containing preparations threaten reproducibility.
-
Renal OCT2/MATE1 Inhibition by 5-HT3 Antagonists
2026-09-09
George and colleagues compared five 5-HT3 antagonist drugs in cellular models of the renal organic cation transporters OCT2 and MATE1. Their findings show that inhibition is transporter- and compound-dependent, providing a mechanistic basis for studying altered renal secretion of cationic drugs while underscoring the limits of extrapolating in vitro results directly to clinical drug interactions.
-
Diethylmaleate: From GSH Depletion to Translation
2026-09-08
Diethylmaleate is more than a redox stressor: it is a causal probe for testing how glutathione buffering, GST activity, ROS, apoptosis, and chemical sensitivity interact. This thought-leadership guide translates evidence from an insecticide-resistance model into disciplined assay design and translational decision-making.
-
Paroxetine Mesylate: Reliable Cell Assays
2026-09-08
A scenario-driven guide to using Paroxetine Mesylate (SKU C8698) in cell viability, proliferation, and cytotoxicity workflows. It connects documented molecular activity with practical controls, dose interpretation, solution handling, and evidence-based vendor selection.
-
H89 Reverses ABCB1-Mediated Colorectal Cancer MDR
2026-09-07
The 2025 Biomedicines study identifies H89 as a functional inhibitor of ABCB1-mediated drug efflux in multidrug-resistant colorectal cancer cells. By reducing ABCB1 ATPase activity without changing transporter expression, H89 increased intracellular doxorubicin and vincristine and restored drug sensitivity, while also providing a mechanistic basis for future resistance-reversal studies.
-
Alternariol: From Foodborne Toxin to Fibrosis Biology
2026-09-07
Alternariol is moving from a food-contaminant concern to a mechanistic tool for studying hepatic stellate cell activation, fibrosis biology, cytochrome P450 metabolism, and toxin mitigation. This article connects current evidence with practical assay design and translational decision-making.
-
HyperScribe All in One mRNA Synthesis Kit Workflow
2026-09-05
Build ARCA-capped, polyadenylated mRNA for translation, vaccine, RNAi, and functional assays with a single coordinated workflow. The kit’s co-transcriptional capping, DNase cleanup, and enzymatic tailing simplify reproducible RNA preparation while preserving flexibility for neoantigen research.
-
Molidustat (BAY85-3934) Experimental Workflows
2026-09-04
Molidustat (BAY85-3934) enables controlled HIF-PH inhibition for erythropoietin stimulation, chronic kidney disease anemia studies, and oxygen-sensing assays. This workflow-focused guide connects biochemical potency with cell-based hypoxia models and the Septin4–VHL–HIF-1α mechanism while emphasizing solvent control, time-course design, and translational limits.
-
Live-Dead Cell Staining Kit: 5 Lab Scenarios
2026-09-04
This scenario-driven guide explains how the Live-Dead Cell Staining Kit, SKU K2081, supports interpretable cell viability, cytotoxicity, microscopy, and flow cytometry workflows. It connects Calcein-AM Propidium Iodide staining with practical decisions about controls, 3D models, data interpretation, and vendor reliability.
-
GST-Driven Lambda-Cyhalothrin Resistance in M. usitatus
2026-09-03
Dong and colleagues identify MuGSTs1 as a functional contributor to lambda-cyhalothrin resistance in Megalurothrips usitatus, linking GST activity with antioxidant protection rather than treating gene expression as a merely correlative marker. Inhibition with diethyl maleate weakened antioxidant capacity and markedly increased insecticide sensitivity, providing a mechanistic framework for resistance biology and experimental redox research.
-
Protein A/G Magnetic Co-IP/IP Kit Workflow
2026-09-03
Translate the BATF2–ATF3 mechanism in intervertebral disc degeneration into a controlled co-IP workflow with recombinant Protein A/G magnetic beads. This guide covers endogenous interaction validation, ubiquitination-focused follow-up, mass-spectrometry preparation, antibody purification, and practical troubleshooting.
-
How Multipass ER Translocons Assemble
2026-09-02
Sundaram and colleagues show that the endoplasmic reticulum translocon is assembled dynamically around translating multipass membrane proteins. Their study identifies the PAT, GEL, and BOS complexes as substrate-responsive components that join Sec61 and TRAP while displacing OST, clarifying how nascent-chain features shape membrane-protein biogenesis.
-
EZ Cap™ EGFP mRNA (5-moUTP) for Cell Assays
2026-09-02
A scenario-based guide to using EZ Cap™ EGFP mRNA (5-moUTP), SKU R1016, to separate delivery and expression variability from true changes in cell viability, proliferation, or cytotoxicity. The article covers assay design, handling, delivery optimization, data interpretation, and practical product-selection criteria.
-
Chlorin e6: Designing Better PDT Assays
2026-09-01
Chlorin e6 enables controlled photodynamic therapy experiments, but assay quality depends on more than ROS generation. This guide connects Ce6 chemistry, light dosimetry, biomaterial design, and wound-infection readouts to improve cancer research photodynamic therapy and antibacterial study design.
-
Marein Restores Mitoxantrone Sensitivity via ABCG2
2026-09-01
The 2024 Biochemical Pharmacology study identifies marein, a flavonoid from Coreopsis tinctoria Nutt, as a competitive inhibitor of the ABCG2 drug-efflux transporter. By increasing intracellular exposure to ABCG2 substrates, including Mitoxantrone, marein restored chemotherapy sensitivity in resistant cancer-cell models and implicated the conserved F439 residue in transporter–drug interactions.